Ruxolitinib Cream Shows Promise for Hidradenitis Suppurativa

Treatment with the topical JAK inhibitor reduced abscess and inflammatory nodules in a phase 2 randomized, controlled trial in patients with mild hidradenitis suppurativa.

Related Keywords

United States , California , University Of Southern California , Boston , Massachusetts , American , Martinaj Porter , P Jenniferl Hsiao , Los Angeles , Beth Israel Deaconess Medical Center , Harvard Medical School , American Academy Of Dermatology , American Academy , Southern California , Hidradenitis Suppurativa , Skin And Soft Tissue Infection , Abscess , Nodule , Otolaryngology , Nt Specialty , Ead And Neck Surgery Ent Speciality , Dermatoses , Skin Disorders , Skin Diseases , Dermatitis , Atopic Dermatitis , Atopic Eczema , Board Certification , Boards , Oard Recertification , Common Cold , Cute Nasopharyngitis , Spain , Pruritus , Pruritis , Pitch , Topical Therapy , Vitiligo ,